research use only
Cat.No.S8880
| Related Targets | HDAC PARP ATM/ATR DNA-PK WRN DNA/RNA Synthesis Topoisomerase PPAR Sirtuin Casein Kinase |
|---|---|
| Other DNA alkylator Inhibitors | Lomeguatrib Methyl methanesulfonate Tretazicar (CB1954) Semustine Treosulfan Phosphoramide mustard cyclohexanamine |
|
In vitro |
Water : 7 mg/mL Ethanol : 4 mg/mL |
|
In vivo |
|||||
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.
| Molecular Weight | 397.33 | Formula | C9H18N2O3Pt |
Storage (From the date of receipt) | 3 years -20°C(in the dark) powder |
|---|---|---|---|---|---|
| CAS No. | 135558-11-1 | -- | Storage of Stock Solutions | Solutions are unstable. Prepare fresh or purchase small, pre-packaged sizes. Repackage upon receipt. | |
Read more about storage stability CAS number
| Features |
This product is not recommended to be dissolved in dimethylsulfoxide (DMSO). Lobaplatin should not be dissolved in sodium chloride solution, which induces its degradation.
|
|---|---|
| In vivo |
Lobaplatin has excellent anticancer activity in vivo against a number of murine experimental tumors, including a cisplatin-resistant P388 line. |
References |
|
(data from https://clinicaltrials.gov, updated on 2025-07-30)
| NCT Number | Recruitment | Conditions | Sponsor/Collaborators | Start Date | Phases |
|---|---|---|---|---|---|
| NCT07093931 | NOT_YET_RECRUITING | Breast Cancer |
Shandong Cancer Hospital and Institute |
2025-08-01 | PHASE4 |
| NCT06688175 | ENROLLING_BY_INVITATION | Nasopharyngeal Neoplasms; Elderly; Chemotherapy |
The First Affiliated Hospital of Xiamen University |
2024-11-13 | PHASE2 |
| NCT05766605 | UNKNOWN | Hepatocellular Carcinoma Resectable |
Zhujiang Hospital |
2023-01-01 | PHASE3 |
| NCT05701436 | UNKNOWN | Liver, Cancer of, Primary Resectable |
Zhujiang Hospital |
2022-09-01 | PHASE3 |
| NCT05780294 | NOT_YET_RECRUITING | Nasopharyngeal Carcinoma; Leucogen; Chemotherapy; Myelosuppression |
Sun Yat-sen University |
2023-04-01 | PHASE3 |
| NCT06169410 | UNKNOWN | Advanced Gastric Cancer |
Yang Jianjun, PhD |
2023-12-30 | PHASE4 |
Read more about Clinical Trials
Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.